Study Stopped
recruitement difficulties
Impact of Male Smoking on the Couple's Infertility
TABAFERTIMASC
1 other identifier
interventional
154
1 country
2
Brief Summary
About 15% of couples consult for difficulties achieving pregnancy. In about two-thirds of cases, a male component is identified, but is not always sufficient to explain infertility. In the majority of cases, the cause cannot be clearly identified and multiple abnormalities may be detected in both partners. Many factors concerning lifestyle and environment (medications, alcohol, smoking, pollution, exposure to heat, toxins, xenobiotic oestrogens, etc.) may impact on fertility. These factors may also impact on the fertility of the children conceived, which is described as an intergenerational effect (alteration of the fertility of boys exposed to smoking in utero). Few scientific studies with a high level of proof have been published on the impact of smoking on the couple's fertility. Gonadal functioning and the quality of gametes can be altered by these environmental factors, which may trigger a process of apoptosis or alteration of the DNA of gametes (sperm DNA fragmentation). Other modifications include DNA methylation and histone acetylation, which control gene expression and are grouped under the term epigenetic modifications. More recently, oestrogens has been shown to be involved in male reproductive function by acting on spermatogenesis, spermiogenesis and epididymal maturation. Demonstration of an active aromatase (Arom) (mRNA, protein and activity) in ejaculated human spermatozoa suggests the synthesis of small quantities of oestrogens in spermatozoa. The study of transcript profiles could provide information about the quality of spermatogenesis and/or spermiogenesis and during the first steps of embryonic development. Confocal microscopy has colocalized the aromatase on the head, midpiece and tail and can be used to assess the quality of the acrosome with anti-CD-46 monoclonal antibody. Even low concentrations of xenobiotic oestrogens can exert biological effects on certain functions of murine or human spermatozoa, accelerating capacitation and the acrosome reaction. These factors are all the more effective when they act in combination, as human gametes appear to be more sensitive to their action than murine gametes All studies conducted to date have investigated the impact of toxins either on one of the partners or in the children born to the couple. No detailed and high-level scientific study has studied both partners and the quality of their embryos.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Dec 2012
Longer than P75 for not_applicable
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
December 5, 2012
CompletedFirst Submitted
Initial submission to the registry
June 10, 2016
CompletedFirst Posted
Study publicly available on registry
June 17, 2016
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 1, 2018
CompletedStudy Completion
Last participant's last visit for all outcomes
October 1, 2018
CompletedJune 12, 2026
June 1, 2026
5.8 years
June 10, 2016
June 10, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Carbon monoxide
in expired air using CO-tester®
3 months
Cotinine rate (micromol/L)
quantitative dosages of blood and / or seminal fluid or in the hair
3 months
Study Arms (2)
infertile couples
EXPERIMENTALsmoking behavior
Fertile couples
ACTIVE COMPARATORsmoking behavior
Interventions
Eligibility Criteria
You may qualify if:
- Fertile couples = control cases (with spontaneously conceived a child with a time required to design less than 12 months) and whose wife gives birth in one of the two maternity hospitals participating in the study
- All couples candidates for AMP: reproductive age couples (Female age \<35 years of age men \<40 years), infertility (primary infertility, inability to conceive after 12 months of no sex protected). 1st or 2nd attempt at in vitro fertilization
- For infertile couples, couples in which we note
You may not qualify if:
- where the partner does not exhibit anovulation or tubal pathology-proven utero, whose ovarian reserve is normal (FSH and estradiol rate J2 / 3 of cycle) ,.
- Female age \> 35 years Women\> 45 years
- Co- infections of one of the two members of the couple (or 2) by HIV, HBV and / or HCV
- Severe Oligospermia humans ( \<5000 000 sperm) or azzoospermie
- A normospermie or moderate oligozoospermia (5-20 million sperm per ml) nonidiopathic
- Will also be excluded couples where the partner has anovulation or uterotubal proven pathology , impaired ovarian reserve or chronic viral disease
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (2)
CHU Amiens
Amiens, 80054, France
CHU Caen
Caen, 14033, France
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Aviva DEVAUX, PhD
CHU Amiens
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NON RANDOMIZED
- Masking
- NONE
- Purpose
- BASIC SCIENCE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
June 10, 2016
First Posted
June 17, 2016
Study Start
December 5, 2012
Primary Completion
October 1, 2018
Study Completion
October 1, 2018
Last Updated
June 12, 2026
Record last verified: 2026-06